Replies to post #245416 on Elite Pharmaceuticals Inc (ELTP)

[Couch]

Let me help you by putting two and one together. This may be hard to grasp. Elite has 3 pathways that lead the company to the Nasdaq. 2 of them are based on the newer generic pipeline and the 3rd is based on the immediacy of getting SequestOx approved and validating Elite's ADT.

The current PPS doesn't include the value of any of those 3 pathways particularly not the ADT pipeline.

So indeed the current PPS is based on the existing generics selling today - plus the experience of Nasrat himself.......a BP veteran proven in the generic marketplace.

The whole argument regarding whether the current PPS is valued accordingly is laughable.

I have my hard earned money and continue to buy shares at these prices. I know what I own and I know the company is undervalued on the generic pipeline alone.